Summary
Insulin secretion after oral (100 g) and i.v. glucose (0.33 g/kg b.w.) was studied in 14 patients with 21-trisomy (Down's syndrome) and in 18 normal subjects. Plasma immunoreactive insulin (IRI), fasting and at predetermined time intervals during each glucose load, was measured by a double antibody method (Hales-Randle). Tolerance to oral glucose in Down's patients was found to be normal though a flat, late peaked glycaemic response was characteristic of the group. Fasting IRI and insulin levels after oral glucose in patients did not significantly differ from those in the normal group. After i.v. glucose, the patients showed a slower decline of the blood sugar, maintaining significantly higher levels than the normals at 30, 40, 50 and 60 min after the glucose load. However, the peripheral glucose uptake expressed by the K index (Conard) did not significantly differ from the normal despite the lower K values in the patients. Insulin release after i.v. glucose showed some differences between both groups. — The present study cannot support a causal relationship between D.M. and the 21-trisomy through an altered insulin secretion.
Article PDF
Avoid common mistakes on your manuscript.
References
Farquhar, J.W.: Diabetic children in Scotland and the need for care. Scot. Med. J.7, 119–123 (1962).
Milunsky, A., Neurath, P.W.: Diabetes mellitus in Down's syndrome. Archs. Envir. Hlth.17, 372–376 (1968).
Serrano-Ríos, M., Ramos, F., Rodriguez-Miñón, J.L., Vivanco, F.: Studies in Prediabetes. Insulin response to oral glucose, Intravenous Tolbutamide and Rapid Intravenous glucose infusion in genetic prediabetics. Diabetología6, 392–398 (1970).
Fajans, S.S., Conn, J.W.: Prediabetes, Subclinical Diabetes and latent chemical Diabetes. Interpretation, Diagnosis and Treatment. In: “On the Nature and Treatment of Diabetes Mellitus”. Chapter 46, pp. 641–656. Editors: Leibel, B.S., Wrenshall, G.A. Amsterdam, New York: Excerpta Medica Foundation, 1965.
Conard, V., Franckson, J. R. M., Bastenie, P.A., Kestens, J., Kóvacs, L.: Etude critique du triangle d'hyperglycemie intraveineux chez l'homme normal et determination d'un “coefficient d'assimilation glucidique”. Arch. int. Pharmacodyn.13, 277–292 (1953).
Hoffmann, W.S.: A rapid photoelectric method for the determination of glucose in blood and urine. J. biol. Chem.120, 51–55 (1937).
Hales, C.N., Randle, P.J.: Immunoassay of insulin with insulin-antibody precipitate. Biochem. J.88, 137–146 (1963).
Runge, G.H.: Glucose tolerance in Mongolism. Amer. J. ment. Defic.47, 822–828 (1959).
Milunsky, A., Marks, V., Samols, E.: Insulin and glucose response to glucagon in Down's syndrome. Letter to the Editor. The Lancet1967 II, 1093–1094.
Milunsky, A., Lowy, C., Rubenstein, A.H., Wright, A.D.: Carbohydrate tolerance, growth hormone and insulin levels in mongolism. Develop. Med. Child. Neurol.10, 25–31 (1968).
Benda, C. E.; Down's syndrome. Mongolism and its management, pp. 109–117. New York, London: Grune and Stratton 1969.
Milunsky, A.: Glucose intolerance in the parents of children with Down's syndrome. Amer. J. ment. Defic.74, 475–478 (1970).
Burch, P.R.J., Milunsky, A.: Early onset Diabetes mellitus in the general and Down's syndrome populations. Genetics, Etiology and Pathogenesis. Hypothesis. The Lancet1969 I, 554–558.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Serrano-Ríos, M., San Roman Cos Gayon, C., Sordo, M.T. et al. Insulin secretion in Down's syndrome. Diabetologia 9, 50–52 (1973). https://doi.org/10.1007/BF01226001
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01226001